Co-tenidone
From Wikipedia, the free encyclopedia
|
Co-tenidone
|
|
| Combination of | |
| Atenolol | Beta blocker |
| Chlortalidone | Thiazide diuretic |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Co-tenidone (BAN) is a non-proprietary name used to denote a combination of atenolol and chlortalidone. Co-tenidone is used in the treatment of hypertension. The use of β-blockers in hypertension was downgraded in June 2006 in the United Kingdom to fourth-line as they perform less well than other drugs, and that atenolol, the most frequently used β-blocker, at usual doses carries an unacceptable risk of provoking type 2 diabetes.[1]
[edit] Formulation
Two strengths of co-amilozide is currently available in the UK:
- 50 mg atenolol and 12.5 mg chlortalidone , BAN of Co-tenidone 50/12.5
- 100 mg atenolol and 25 mg chlortalidone , BAN of Co-tenidone 100/25
[edit] References
- British National Formulary 54 September 2007
[edit] Footnotes
- ^ Sheetal Ladva (28/06/2006). NICE and BHS launch updated hypertension guideline. National Institute for Health and Clinical Excellence.
|
||||||||||||||||||||

